Journal Article

Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab

Heide, Lutz, Held, Nadja, Petersen, Albert

2017

Overview

Substandard and falsified medical products present a serious threat to public health, especially in low- and middle-income countries. Their identification using pharmacopeial analysis is expensive and requires sophisticated equipment and highly trained personnel. Simple, low-cost technologies are required in addition to full pharmacopeial analysis in order to accomplish widespread routine surveillance for poor-quality medicines in low- and middle-income countries. Ten faith-based drug supply organizations in seven countries of Africa and Asia were each equipped with a Minilab of the Global Pharma Health Fund (GPHF, Frankfurt, Germany), suitable for the analysis of about 85 different essential medicines by thin-layer chromatography. Each organization was asked to collect approximately 100 medicine samples from private local medicine outlets, especially from the informal sector. The medicine samples were tested locally according to the Minilab protocols. Medicines which failed Minilab testing were subjected to confirmatory analysis in a WHO-prequalified medicine quality control laboratory in Kenya. Out of 869 medicine samples, 21 were confirmed to be substandard or falsified medical products. Twelve did not contain the stated active pharmaceutical ingredient (API), six contained insufficient amounts of the API, and three showed insufficient dissolution of the API. The highest proportion of substandard and falsified medicines was found in Cameroon (7.1%), followed by the Democratic Republic of Congo (2.7%) and Nigeria (1.1%). Antimalarial medicines were most frequently found to be substandard or falsified (9.5% of all antimalarials). Thin-layer chromatography according to the Minilab protocols was found to be specific and reproducible in the identification of medicines which did not contain the stated API. Since only samples which failed Minilab testing were subjected to confirmatory testing using pharmacopeial methods, this study did not assess the sensitivity of the Minilab methodology in the detection of substandard medicines, and may underestimate the prevalence of poor-quality medicines. Surveillance for poor-quality medicines can be carried out by local organizations in low- and middle-income countries using a simple, low-cost technology. Such surveillance can identify an important subgroup of the circulating substandard and falsified medical products and can help to prevent them from causing harm in patients. A collaboration of the national drug regulatory authorities with faith-based organizations and other NGOs may therefore represent a promising strategy towards the Sustainable Development Goal of \"ensuring access to quality medicines\".

• Publisher: Public Library of Science,Public Library of Science (PLoS)
• Subject: Africa / Analysis / Antimicrobial agents / Asia / Chromatography / Chromatography, Thin Layer / Cost analysis / Counterfeit Drugs - analysis / Counterfeit Drugs - supply & distribution / Counterfeiting / Drug dosages / Health surveillance / Income / Laboratories / Laboratories - organization & administration / Laws, regulations and rules / Medical equipment / Medical ethics / Medicine / Medicine and Health Sciences / NGOs / Nongovernmental organizations / Outlets / People and Places / Pharmaceutical industry / Pharmaceuticals / Pharmacology / Physical Sciences / Production management / Public health / Quality control / Research and Analysis Methods / Sensitivity analysis / Spectrum analysis / Surveillance / Surveys and Questionnaires / Sustainable development / Test procedures / Thin layer chromatography